Angiotensin converting enzyme inhibitors and interstage failure in infants with hypoplastic left heart syndrome

Abstract

Angiotensin converting enzyme inhibitor therapy did not demonstrate a beneficial effect on interstage failure among infants with hypoplastic left heart syndrome, even when patient characteristics associated with the use of angiotensin converting enzyme inhibitors were considered.